MedPath

Extended Treatment with Statin on Atheroma Regression Evaluated by Intravascular Ultrasound with Virtual Histology (Extended TRUTH Study)

Not Applicable
Conditions
Patients with stable angina or unstable angina
Registration Number
JPRN-UMIN000004627
Lead Sponsor
Kanagawa PTCA Conference
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
119
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients meeting the contraindications or relative contraindications for pitavastatin and pravastatin 2)Patients with hepatic disorder or with AST(GOT) or ALT(GPT) greater than 2.5 times of the upper limits of normal 3)Patients with renal dysfunction(serum creatinine 2.0mg/dL or higher) 4)Patients with a history of severe muscular disorder or with CK(CPK) greater than 2.5 times of the upper limit of normal 5)Patients with acute myocardial infarction occurred within 24 hours 6)Patients having failed to PCI 7)Patients with cerebrovascular accident occurred within 1 month 8)Patients with concurrent or a history of malignant tumor within 5 years prior to start of the investigationak drug 9)Patients receiving LDL apheresis 10)Patients with homozygous familial hypercholesterolemia 11)Patients requiring the following prohibited concomitant drugs 12)Drug abusers 13)Patients participating in other studies 14)Patients ineligible for the study determined by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath